Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Merimna AB
AB
In liquidation
Org 5591634026
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 8 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Merimna AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2019: 0M
0M
2019
2020: 0M
0M
2020
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2019: 0M
0M
2019
2020: 0M
0M
2020
Income statement
SEK thousands
Item
2020
2019
Revenue
0
0
Staff expenses
—
—
EBITDA
−1
0
Depreciation & amort.
−0
−0
EBIT
−1
0
Net financials
—
—
Profit before tax
−1
0
Tax
−0
−0
Net profit
−1
0
Balance sheet
SEK thousands
Item
2020
2019
Total assets
49
50
Equity
49
50
Long-term debt
0
0
Short-term debt
0
0
Total debt
—
—
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2019
2020
Equity ratio
100,0 %
This company
38,2 %
Market median
This company
Market median
162% above market
2019
2020
Return on equity
−2,0 %
This company
18,4 %
Market median
This company
Market median
111% below market
2019
2020
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2019
2020
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2019
2020
Debt / equity
0,00×
This company
0,62×
Market median
This company
Market median
100% below market
2019
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-06-01 – 2019-09-30
View
PDF
More on Merimna AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
